Skip to main content
Journal cover image

Common non-epigenetic drugs as epigenetic modulators.

Publication ,  Journal Article
Lötsch, J; Schneider, G; Reker, D; Parnham, MJ; Schneider, P; Geisslinger, G; Doehring, A
Published in: Trends in molecular medicine
December 2013

Epigenetic effects are exerted by a variety of factors and evidence increases that common drugs such as opioids, cannabinoids, valproic acid, or cytostatics may induce alterations in DNA methylation patterns or histone conformations. These effects occur via chemical structural interactions with epigenetic enzymes, through interactions with DNA repair mechanisms. Computational predictions indicate that one-twentieth of all drugs might potentially interact with human histone deacetylase, which was prospectively experimentally verified for the compound with the highest predicted interaction probability. These epigenetic effects add to wanted and unwanted drug effects, contributing to mechanisms of drug resistance or disease-related and unrelated phenotypes. Because epigenetic changes might be transmitted to offspring, the need for reliable and cost-effective epigenetic screening tools becomes acute.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Trends in molecular medicine

DOI

EISSN

1471-499X

ISSN

1471-4914

Publication Date

December 2013

Volume

19

Issue

12

Start / End Page

742 / 753

Related Subject Headings

  • Pharmaceutical Preparations
  • Immunology
  • Humans
  • Histone Deacetylases
  • Epigenomics
  • Epigenesis, Genetic
  • Drug Therapy
  • DNA Repair
  • DNA Methylation
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lötsch, J., Schneider, G., Reker, D., Parnham, M. J., Schneider, P., Geisslinger, G., & Doehring, A. (2013). Common non-epigenetic drugs as epigenetic modulators. Trends in Molecular Medicine, 19(12), 742–753. https://doi.org/10.1016/j.molmed.2013.08.006
Lötsch, Jörn, Gisbert Schneider, Daniel Reker, Michael J. Parnham, Petra Schneider, Gerd Geisslinger, and Alexandra Doehring. “Common non-epigenetic drugs as epigenetic modulators.Trends in Molecular Medicine 19, no. 12 (December 2013): 742–53. https://doi.org/10.1016/j.molmed.2013.08.006.
Lötsch J, Schneider G, Reker D, Parnham MJ, Schneider P, Geisslinger G, et al. Common non-epigenetic drugs as epigenetic modulators. Trends in molecular medicine. 2013 Dec;19(12):742–53.
Lötsch, Jörn, et al. “Common non-epigenetic drugs as epigenetic modulators.Trends in Molecular Medicine, vol. 19, no. 12, Dec. 2013, pp. 742–53. Epmc, doi:10.1016/j.molmed.2013.08.006.
Lötsch J, Schneider G, Reker D, Parnham MJ, Schneider P, Geisslinger G, Doehring A. Common non-epigenetic drugs as epigenetic modulators. Trends in molecular medicine. 2013 Dec;19(12):742–753.
Journal cover image

Published In

Trends in molecular medicine

DOI

EISSN

1471-499X

ISSN

1471-4914

Publication Date

December 2013

Volume

19

Issue

12

Start / End Page

742 / 753

Related Subject Headings

  • Pharmaceutical Preparations
  • Immunology
  • Humans
  • Histone Deacetylases
  • Epigenomics
  • Epigenesis, Genetic
  • Drug Therapy
  • DNA Repair
  • DNA Methylation
  • Animals